Science
FDA-approved epilepsy drug may help reverse osteoarthritis damage
ScienceDaily
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
Read the full story at the original publisher
ScienceDaily →
-
Nations seek reset at UN talks as nature goals off trackPhys.org Center2 days ago
-
The painstaking task of cataloging the world's speciesPhys.org Center2 days ago
-
Factoring daily weather extremes into glacier models reveals greater ice loss and faster sea-level risePhys.org Center2 days ago
Leave a Reply